Patents Assigned to FASMAC CO., LTD.
-
Patent number: 12168804Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.Type: GrantFiled: December 18, 2017Date of Patent: December 17, 2024Assignees: NIPPN CORPORATION, FASMAC CO., LTD.Inventors: Mika Tsuna, Yoshitaka Harada, Yasuhiro Seto, Kazuto Takasaki
-
Patent number: 12163195Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.Type: GrantFiled: November 9, 2023Date of Patent: December 10, 2024Assignees: NIPPN CORPORATION, FASMAC CO., LTD.Inventors: Mika Tsuna, Yoshitaka Harada, Yasuhiro Seto, Kazuto Takasaki
-
Patent number: 12146135Abstract: The present invention relates to a method of editing a filamentous fungal genome by direct introduction of a genome editing protein molecule or complex. The method includes three modes. In the first mode, a genome editing protein molecule or complex for a target gene is directly introduced into a cell of an Aspergillus fungus, to edit a gene in the Aspergillus fungal genome. In the second mode, a genome editing protein molecule or complex for a target region in a filamentous fungal genome, and a desired DNA fragment, are directly introduced into a filamentous fungal cell, to knock-in the DNA fragment to a desired target site in the filamentous fungal genome. In the third mode, genome editing protein molecules or complexes for plural target genes are directly introduced into a filamentous fungal cell, to carry out simultaneous editing of the plural genes in the filamentous fungal genome.Type: GrantFiled: August 25, 2017Date of Patent: November 19, 2024Assignees: NATIONAL RESEARCH INSTITUTE OF BREWING, FASMAC CO., LTD.Inventors: Kazuhiro Iwashita, Ken Oda, Kohei Shimamoto, Yusaku Wada
-
Publication number: 20240167104Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.Type: ApplicationFiled: November 9, 2023Publication date: May 23, 2024Applicants: NIPPN CORPORATION, FASMAC CO., LTD.Inventors: Mika TSUNA, Yoshitaka HARADA, Yasuhiro SETO, Kazuto TAKASAKI
-
Patent number: 11705218Abstract: In one embodiment, provided are a method for analyzing at least one nucleic acid that can conveniently and highly accurately analyze even a very small number of analyte at least one nucleic acid. In one embodiment, the present invention relates to a method for analyzing at least one nucleic acid, comprising: a library preparation step of preparing a library comprising at least one standard nucleic acid of specific copy number(s) and at least one analyte nucleic acid in a same system; a calibration curve data generation step of generating calibration curve data based on the copy number(s) of the at least one standard nucleic acid of specific copy number(s); and an analyte nucleic acid analysis step of identifying at least one nucleotide sequence of the analyte nucleic acid while identifying the number(s) of the at least one nucleotide sequence of the at least one analyte nucleic acid using the calibration curve data.Type: GrantFiled: December 18, 2019Date of Patent: July 18, 2023Assignees: Ricoh Company, Ltd., FASMAC CO., LTD.Inventors: Yusuke Osaki, Hirotaka Unno, Yudai Kawashima, Michie Hashimoto, Masayuki Yumoto, Satoshi Nakazawa, Yuki Yonekawa, Takahiro Matsudaira, Eri Nishiyama
-
Publication number: 20220170076Abstract: A method for manufacturing a device is provided, in which a known quantity of a reagent is reliably immobilized in a reaction field, which can be stored at room temperature, and with which the performance of a real-time PCR apparatus can be correctly evaluated. The method is a method for manufacturing a device having at least one well, in which a specific number of copies of a nucleic acid in the at least one well are immobilized in a reaction field. The method includes a nucleic acid extraction step of extracting the nucleic acid with an enzyme and a drying deactivation step of deactivating the enzyme by drying at 5° C. to 45° C.Type: ApplicationFiled: November 22, 2021Publication date: June 2, 2022Applicants: Ricoh Company, Ltd., Fasmac Co., Ltd.Inventors: Hirotaka UNNO, Satoshi Nakazawa, Yuuki Yonekawa, Michie Hashimoto, Satoshi Futo, Mari Onishi, Riztyan
-
Publication number: 20210403997Abstract: Provided is a device including a well provided in a number of at least one, wherein a nucleic acid having at least one of a full-length nucleotide sequence and a partial nucleotide sequence of rRNA or rDNA is contained in a defined copy number in at least one well of the well, and wherein the defined copy number of the nucleic acid having at least one of a full-length nucleotide sequence and a partial nucleotide sequence of rRNA or rDNA is 1,000 or less.Type: ApplicationFiled: December 16, 2019Publication date: December 30, 2021Applicants: Ricoh Company, Ltd., FASMAC CO., LTD.Inventors: Michie HASHIMOTO, Hirotaka UNNO, Satoshi NAKAZAWA, Yuki YONEKAWA, Satoshi FUTO, RIZTYAN
-
Publication number: 20210024979Abstract: Novel means that enables detection of the monocytogenes bacterium alone distinctly from other bacteria belonging to the genus Listeria with sufficiently high accuracy is disclosed. The present inventors intensively analyzed the genome of the monocytogenes bacterium to identify two genes (the lmo0084 gene and the lmo2736 gene) as target regions with which the monocytogenes bacterium can be specifically detected distinctly from other bacteria belonging to the genus Listeria utilizing a nucleic acid amplification method. By a further intensive study of the base sequences of these two genes, primer setting regions for highly accurate, specific detection of the monocytogenes bacterium alone were identified, and preferred particular examples of PCR primer sets, LAMP primer sets, and real-time PCR primer-probe sets were established.Type: ApplicationFiled: December 18, 2017Publication date: January 28, 2021Applicants: NIPPON FLOUR MILLS CO.,LTD., FASMAC CO., LTD.Inventors: Mika TSUNA, Yoshitaka HARADA, Yasuhiro SETO, Kazuto TAKASAKI
-
Publication number: 20200040330Abstract: The present invention relates to a method of editing a filamentous fungal genome by direct introduction of a genome editing protein molecule or complex. The method includes three modes. In the first mode, a genome editing protein molecule or complex for a target gene is directly introduced into a cell of an Aspergillus fungus, to edit a gene in the Aspergillus fungal genome. In the second mode, a genome editing protein molecule or complex for a target region in a filamentous fungal genome, and a desired DNA fragment, are directly introduced into a filamentous fungal cell, to knock-in the DNA fragment to a desired target site in the filamentous fungal genome. In the third mode, genome editing protein molecules or complexes for plural target genes are directly introduced into a filamentous fungal cell, to carry out simultaneous editing of the plural genes in the filamentous fungal genome.Type: ApplicationFiled: August 25, 2017Publication date: February 6, 2020Applicants: NATIONAL RESEARCH INSTITUTE OF BREWING, FASMAC CO., LTD.Inventors: Kazuhiro IWASHITA, Ken ODA, Kohei SHIMAMOTO, Yusaku WADA